EDITORIALS

The Means, the Mission, and the Pledge of The Oncologist

Bruce A. Chabner, Frank M. Balis, Gregory A. Curt, Eli Glatstein, John E. Niederhuber, H.M. Pinedo, Martin J. Murphy, Jr.
Oncologist 2004; 9: 1-2 ; doi:10.1634/theoncologist.9-1-1
[Full Text] [PDF]  

Ethical Conflict in Providing Informed Consent for Clinical Trials: A Problematic Example from the Gynecologic Cancer Research Community

Maurie Markman
Oncologist 2004; 9: 3-7 ; doi:10.1634/theoncologist.9-1-3
[Abstract] [Full Text] [PDF]  

FDA Drug Approval Summaries: Oxaliplatin

Amna Ibrahim, Steven Hirschfeld, Martin H. Cohen, Donna J. Griebel, Grant A. Williams, Richard Pazdur
Oncologist 2004; 9: 8-12 ; doi:10.1634/theoncologist.9-1-8
[Abstract] [Full Text] [PDF]  

Recognition and Management of Hereditary Breast Cancer Syndromes

Darcy L. Thull, Victor G. Vogel
Oncologist 2004; 9: 13-24 ; doi:10.1634/theoncologist.9-1-13
[Abstract] [Full Text] [PDF]  

Anemia in Stage II and III Breast Cancer Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Chemotherapy

Jeffrey Kirshner, Marianne Hatch, Daniel D. Hennessy, Moshe Fridman, Rima E. Tannous
Oncologist 2004; 9: 25-32 ; doi:10.1634/theoncologist.9-1-25
[Abstract] [Full Text] [PDF]  

Topotecan Dosing Guidelines in Ovarian Cancer: Reduction and Management of Hematologic Toxicity

Deborah K. Armstrong
Oncologist 2004; 9: 33-42 ; doi:10.1634/theoncologist.9-1-33
[Abstract] [Full Text] [PDF]  

Diagnosis and Treatment of Cholangiocarcinoma

Christopher D. Anderson, C. Wright Pinson, Jordan Berlin, Ravi S. Chari
Oncologist 2004; 9: 43-57 ; doi:10.1634/theoncologist.9-1-43
[Abstract] [Full Text] [PDF]  

HER1/EGFR Targeting: Refining the Strategy

Román Pérez-Soler
Oncologist 2004; 9: 58-67 ; doi:10.1634/theoncologist.9-1-58
[Abstract] [Full Text] [PDF]  

The Role of Topotecan in the Treatment of Brain Metastases

Eric T. Wong, Anna Berkenblit
Oncologist 2004; 9: 68-79 ; doi:10.1634/theoncologist.9-1-68
[Abstract] [Full Text] [PDF]  

Complementary and Alternative Therapies for Cancer

Barrie R. Cassileth, Gary Deng
Oncologist 2004; 9: 80-89 ; doi:10.1634/theoncologist.9-1-80
[Abstract] [Full Text] [PDF]  

Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy

Jeffrey Patton, Michael Kuzur, William Liggett, Fernando Miranda, Helen Varsos, Lester Porter
Oncologist 2004; 9: 90-96
[Abstract] [Full Text] [PDF]  

The Evolving Role of Epoetin Alfa in Cancer Therapy

David H. Henry
Oncologist 2004; 9: 97-107 ; doi:10.1634/theoncologist.9-1-97
[Abstract] [Full Text] [PDF]  

The Molecular Perspective: DNA Polymerase

David S. Goodsell
Oncologist 2004; 9: 108-109 ; doi:10.1634/theoncologist.9-1-108
[Full Text] [PDF]  

Letter to the Editor

Lodovico Balducci
Oncologist 2004; 9: 110 ; doi:10.1634/theoncologist.9-1-110
[Full Text] [PDF]  

Art Illuminates Patients’ Experience at the Massachusetts General Hospital Cancer Center

Beth Homicki, Eileen K. Joyce
Oncologist 2004; 9: 111-114 ; doi:10.1634/theoncologist.9-1-111
[Full Text] [PDF]  

Reflections

M. Hossein Tirgan, Paul Hetzel
Oncologist 2004; 9: 115-117 ; doi:10.1634/theoncologist.9-1-115
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.